Intestinal Ultrasound Predicts Primary Non-Response and Maintenance Relapse in Upadacitinib-Treated Active Crohn's Disease: A Multicenter, Prospective Cohort Study. He R, Huang Y, Han J, Zhao P, et al. Aliment Pharmacol Ther 2026 Sep 1. doi: 10.1111/apt.70948.

Read + Share

Amedeo Smart

Independent Medical Education